Small airways and early origins of COPD: pathobiological and epidemiological considerations

Francesca Polverino, Joan B. Soriano

Source: Eur Respir J, 55 (3) 1902457; 10.1183/13993003.02457-2019
Journal Issue: March
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Francesca Polverino, Joan B. Soriano. Small airways and early origins of COPD: pathobiological and epidemiological considerations. Eur Respir J, 55 (3) 1902457; 10.1183/13993003.02457-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Omics in population studies: a molecular epidemiology perspective in chronic airway disease
Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome
Year: 2014



Recommendations for epidemiological studies on COPD
Source: Eur Respir J 2011; 38: 1261-1277
Year: 2011



Clinical implications of small airways dysfunction in COPD
Source: International Congress 2017 – From small airways dysfunction to dyspnoea in COPD: from physiology to clinical application
Year: 2017


The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019


Early determinants of airway function: epidemiological and physiological evidence
Source: ISSN=ISSN 1810-6838, ISBN=, page=147
Year: 2007

Latest insights into treatment of small airways diseases
Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD
Year: 2019


Inflammatory cells and airway remodelling in COPD: clinical implications
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019


Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development?
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology
Source: ERS Satellites 2021
Year: 2021

Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities
Source: Eur Respir Rev 2009; 18: 198-212
Year: 2009


Molecular and cytological features of occupational chronic obstructive pulmonary disease in subjects exposed to different environmental factors
Source: International Congress 2015 – Occupational factors in COPD and bronchitis
Year: 2015


Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank
Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient
Year: 2015



Clinical implications of the new concepts regarding COPD pathophysiology
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Year: 2008


COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact
Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Year: 2011


Elucidating the causes and examining the latest clinical findings in pulmonary fibrosis
Source: Eur Respir Rev 2008; 17: 105-107
Year: 2008


The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases?
Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Year: 2011



Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis
Source: International Congress 2018 – Microorganisms and lung ecology: living in peace with bugs
Year: 2018